ZJYL
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
NASDAQ: ZJYL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$2.45
-13.64% today
Updated 2026-06-05
Market cap
$18.94M
P/E ratio
12.10
P/S ratio
0.92x
EPS (TTM)
$0.20
Dividend yield
—
52W range
$2 – $17
Volume
0.3M
WallStSmart proprietary scores
36
out of 100
Grade: D
Sell
Investment rating
2.7
Growth
F5.5
Quality
C+4.5
Profitability
C6.0
Valuation
B1/9
Piotroski F-Score
Weak
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$0.07
-97.14%
12-Month target
$0.07
-97.14%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Negative free cash flow $-4.24M
- Revenue declining -16.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $19.19M | $19.82M | $23.50M | $20.69M | $20.69M |
| Net income | $2.71M | $2.88M | $3.68M | $1.19M | $1.28M |
| EPS | — | — | — | — | $0.20 |
| Free cash flow | $1.54M | $2.99M | $-2.33M | $-3.73M | $-4.24M |
| Profit margin | 14.10% | 14.52% | 15.64% | 5.76% | 5.76% |
Peer comparison
Smart narrative
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares trades at $2.45. representing a P/E of 12.10x trailing earnings. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 2.18, it sits in the grey zone. TTM revenue stands at $20.69M. with profit margins at 5.76%.
Frequently asked questions
What is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's stock price?
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) trades at $2.45, on a P/E of 12.1x and a P/S of 0.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares overvalued?
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares carries a Smart Value Score of 36/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)?
The 12-month analyst consensus target is $0.07, about 97.1% below the current $2.45. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's revenue?
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's trailing twelve-month revenue is $20.69M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Altman Z-Score is 2.18, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.92x
ROE3.72%
Beta7.23
50D MA$2.30
200D MA$4.88
Shares out0.01B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—